Purpose: To evaluate the safety and performance of CO 2 laser-assisted sclerectomy surgery (CLASS). Materials and Methods: CLASS using the IOPtiMate™ system was performed in experimental models and in patients with primary and pseudoexfoliative open-angle glaucoma. CO 2 laser was used to achieve deep scleral ablation. Percolation and perforation rates were recorded. Histopathological analysis was performed on laboratory models, complications were recorded and postoperative intraocular pressure (IOP) was measured.
and adjusted to target Schlemm's canal in human eyes, or the plexus area in pig and rabbit eyes. The CO 2 laser was repeatedly applied with intervals of two to three seconds between applications to allow percolation to take place and be detected. Residual charred tissue was wiped away with a BSS damp Weck-Cel sponge and ablation was continued until sufficient percolation was achieved along a region of at least 3 mm in length ( Figure 1 ). The scleral flap was repositioned and secured with two interrupted 10-0 nylon sutures.
In the living eyes, a high-molecular-weight ophthalmic viscosurgical device (Healon ® 5, Abbott Medical Optics, Santa Ana, California, USA) was applied beneath the flap, the conjunctiva was adequately secured with 2-4 10-0 nylon buried sutures, and the eye was patched with antibiotic and steroid ointments. Living rabbits were anaesthetised using intramuscular ketamine (35 mg/kg) and xylazine (5 mg/kg) whereas patients with glaucoma were operated under subconjunctival anaesthesia with 2 % lidocaine without epinephrine.
All living eyes were treated postoperatively with topical steroids and antibiotic drops.
Mitomycin C (MMC) was not used in the preclinical phase, whereas the application of MMC and its concentration were left to the surgeon's discretion in the clinical trial.
Preclinical Phase
The preclinical trial, as previously described by our group, 20 included an ex vivo (enucleated porcine and human cadaver eyes) and an in vivo model (12 New Zealand white healthy male rabbits). Aqueous percolation sufficiency and rate of perforations during scleral ablation were assessed. Histological examination included evaluation of the scleral crater formed at the ablated sclera, assessment of the dimensions and integrity of the remaining trabeculo-Descemet's membrane, and grading of the mechanical and thermal damage to treated and adjacent tissues.
Assessment of in vivo results focused on the inflammatory reaction, thermal damage at the ablated site, and the healing process.
Clinical Phase
This was a prospective, non-randomised, non-comparative, multinational, multicentre clinical study. 21 The trials were carried out CO 2 Laser-assisted Sclerectomy Surgery for Open-angle Glaucoma and needling procedures were indicated when IOP was above the target pressure of the individual patient as determined by the surgeon.
Decisions about which procedure to perform and the timing of performance were left to the surgeon's discretion. The number of hypotensive medications being used at the six-and 12-month visits was compared with the baseline situation. The 95 % confidence intervals (CIs) were calculated for the mean IOP measurements and for the success rates at six-month follow-up and the 12-month endpoint. A paired t-test was used to determine the significance of the changes in IOP. All tests applied were two-tailed, and a p value of 0.05 or less was considered significant. Data were analysed using the SAS ® software (SAS Institute, Cary, North Carolina, USA).
Statistical Methods

Results
Preclinical Phase
As shown in Table 1 , aqueous percolation was repeatedly achieved without the occurrence of macro-perforations during the procedures.
Tissue histology demonstrated a funnel-shaped scleral crater with a thin residual corneo-scleral layer in the deeper aspect ( Figure 2) . The lateral walls of the crater created in the porcine eyes and in human cadaver eyes showed a thin layer of thermal damage. However, at the bottom of the crater over the exposed plexus/Schlemm's canal where percolation takes place, thermal damage was minimal or absent.
There was no clinical or histological evidence of thermal damage to adjacent tissues such as the iris, ciliary body or cornea.
The mean baseline IOP in rabbits eyes was 16.6 ± 2.8 mmHg (mean ± SD) dropped by 6.3 ± 3.9 mmHg (n=16, p<0.0001) on the first postoperative day and remained 2 mmHg below baseline up to Day 9.
There were no cases of persistent hypotony or ocular hypertension. In 
Clinical Phase
The first 37 patients (from Russia, India and Mexico) have completed one year of follow-up and their results are presented. Twenty-five patients were later recruited in two additional sites (Spain and Italy). The one-year data are being collected and will be published once analysed.
Twenty-eight patients (75.7 %) with POAG and nine (24.3 %) with PEXFG who met the inclusion/exclusion criteria were enrolled in the study. 21 Five patients were excluded from the performance analysis. 21 Twenty-one (56.8 %) were men and the mean age was 63.4 ± 11.8
years. MMC was used in 25 patients (67.56 %).
Safety Analysis
Safety analysis revealed no device malfunctions and there were no device-related macro-perforations. Four cases of micro-perforation were recorded. The AC remained deep and stable in all cases.
Postoperative procedure-related complications occurred in eight patients (21.6 %): peripheral anterior synechiae (2), choroidal detachment (2), wound leak (2), dellen (1) and hyphema (1). All but one complication were graded as mild and resolved spontaneously or with conservative treatment within month after surgery, and none was attributed specifically to the laser treatment. One patient developed choroidal detachment one week postoperatively and was treated using drainage with complete recovery.
Performance Analysis
The preoperative IOP of 26.3 ± 7.8 mmHg (mean ± SD) dropped to Two patients underwent YAG laser goniopuncture. One patient had it done two weeks after the initial surgery whereas the other was performed after four weeks.
Discussion
Manual NPDS achieves IOP reduction by facilitating outflow of aqueous humor through the thin trabeculo-Descemet's membrane.
The procedure is relatively safe but the surgical technique demands a high level of proficiency, with controversial efficacy relative to that of trabeculectomy. 8, 24 Theoretically, laser-assisted glaucoma surgery offers the potential advantage of improved accuracy, repeatability and safety. An increasing number of different radiation sources were examined for penetrating [25] [26] [27] [28] and non-penetrating 22, 25, 29 glaucoma surgery with various success rates.
CO 2 laser is commonly used in laser-assisted operations. 30 Inherent characteristics of the CO 2 laser make it suitable for a simplified non-penetrating filtration surgery, in particular its effective photoablation of dry tissues as well as its effective absorption by any amount of water or aqueous present. CLASS procedure uses the CO 2 laser as a radiation source for gradual removal of scleral tissue layers, leaving the thin trabeculo-Descemet's membrane through which aqueous percolates.
The percolating fluid readily absorbs the laser's energy, protecting the remaining tissue from further ablation and undesired perforation leaving the trabeculo-Descemet's membrane intact.
The feasibility and safety of CLASS using the early prototype (OT-133)
were studied in experimental models 19 and in pilot clinical studies.
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The OT-133 was superseded by the design of the IOPtiMate system, implementing a revised beam-manipulating system, which was designed to improve and refine control of the ablation process and further decrease residual laser-induced thermal damage to the tissue. Higher success rates may be achieved by augmenting the technique with implants or antimetabolites. Longer-term follow-up is required to evaluate the safety and long-term efficacy of CLASS, and to assess its usefulness in a wider spectrum of indications.
In summary, the use of laser technology to improve surgical accuracy is a highly appealing option. The feasibility and safety of CLASS using the IOPtiMate system were successfully demonstrated in all investigated models by the achievement of percolation with no evidence of device-related macro-perforation. n CO 2 Laser-assisted Sclerectomy Surgery for Open-angle Glaucoma
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